News Tagged ‘Baxter International

Baxter faces numerous lawsuits over tainted heparin scandal

blood cells 100x100As many as 300 product-liability lawsuits may be filed in the Illinois state court against drug maker Baxter International Inc., by people injured by or families who lost loved ones to contaminated batches of the heparin. Per a judge’s order last year, attorneys are working to convert an aggregate lawsuit to individual claims against the Deerfield, Illinois-based drug company.

Read the rest of this entry »

Four lawsuits filed in contaminated heparin case

Four lawsuits were filed last month in Cook County, Illinois court against the makers of the heparin, claiming the product the company manufactured was contaminated and caused patients to die.

Read the rest of this entry »

Baxter says it’s not responsible for recent heparin deaths, illness

It’s like a bad dream happening all over again – people falling ill or dying after receiving doses of the heparin. In 2007, tainted doses of heparin killed more than 80 Americans and injured hundreds more. And while investigations into the cause continue, the culprit was found to have been over-sulfated chondroitin sulfate (OSCS) a -mimicking contaminant that made its way into batches of that were manufactured in Baxter International’s plant.

Read the rest of this entry »

FDA announces labeling changes for heparin

The Food and Drug Administration () announced this week safety labeling changes on the heparin to include warnings of fatal medication errors that have resulted in heparin-induced thrombocytopenia (HIT) and -induced thrombocytopenia and thrombosis (HITT), in particular in neonates, or infants less than a year old.

Read the rest of this entry »

Lawmakers debate safety of importing drugs

Congress continues to debate the notion of allowing people to buy inexpensive drug from other countries, as the Obama administration is encouraging, but the stickler seems to be ensuring the safety of those imported drugs, according to Portfolio.

Read the rest of this entry »

Baxter named in contaminated saline syringe lawsuit

Pharmaceutical giant Baxter International faces yet another lawsuit, this time for playing a role in the distribution of a contaminated saline syringe that was used on a woman who afterward suffered serious medical problems that may have led to her death a year later, according to the Hays Daily News.

Read the rest of this entry »

Scientists propose new testing standards for heparin

Scientists are proposing new standards for testing the quality and safety of heparin with new equipment that can analyze a broader range of impurities than the screening tools currently in use, according to the Daily Herald. The proposal stems from last year’s tainted heparin scandal that resulted in the deaths of more than 80 Americans and illness in hundreds more. Batches of were later found to have been contaminated with oversulfated chondroitin sulfate (OSCS) during manufacturing at Baxter International’s plant. OSCS is a -mimicking contaminant that can cause serious allergic reactions in humans.

Read the rest of this entry »

Heparin producer’s insurers file lawsuit

The insurance companies for Scientific Protein Laboratories’ parent company, American Capital Ltd., are suing to nullify the policies with the laboratory, according to The Daily Record. The Wisconsin-based company entered a joint venture with Baxter International Inc. to produce heparin in . Last year, heparin produced at that plant was found to have been contaminated with oversulfated chondroitin sulfate (OSCS), a -mimicking material that can cause life-threatening allergic reactions. The contaminated heparin killed more than 80 people in the U.S. and sickened hundreds more before several batches of the were recalled.

Read the rest of this entry »

Lawmakers call for rule requiring drugs be made in U.S.

Lawmakers’ concern over the U.S. becoming too reliant on foreign countries to produce drugs are calling for a rule to require certain drugs to be made or stockpiled in the U.S., according to the New York Times. The Times quotes Sen. Sherrod Brown of Ohio as saying that relying on other countries to produce our country’s medicines opens the door to “supply disruptions, counterfeit medicines, even bio-terrorism.”

Read the rest of this entry »

FDA launches pilot project to oversee foreign drug products

The FDA announced today that it will launch a voluntary two-year pilot program to help promote the safety of drugs and active drug ingredients made outside the U.S. As part of the Secure Supply Chain program, the will select 100 volunteers to maintain control over drug products beginning with when they are produced until it enters the U.S.

Read the rest of this entry »